The free go-to app for haematology professionals

We now offers a vast amount of Haematology-related tools like the Advanced Myelofibrosis Tool, IPI for Advanced Hodgkin Lymphoma, FLIPI 1&2, Wells Score for DVT & PE, CMML Prognostic Scoring System, and much more.

RED IPHONE

Achievements

5 stars 1

4.8 out of 5 stars in the App Store

iSYScore 250

Named the BEST APP for health professionals by FundacioniSYS for 2 years in a row.

CE

CE approved

Let’s save time & improve the quality of patient care.

We designed the haematology interface to save you time by providing quick and easy access to all the haematology tools that can help your clinical decision-making.

Formulas

With over 40 interactive formulas, we are focused on offering oncology HCPs the information they require instantly at the point of care.

Prognostic Scores

With over 14 prognostic scores tailored for a number of specialties, we cut down a task that took a number of minutes to just a few seconds.

AJCC/TNM Staging

We have integrated the TNM staging criteria from the AJCC to create an easy-to-use and interactive functionality that offer access to the 7th and 8th Edition of the staging criteria.

Toxicity Grading (CTC AE)

We have integrated the TNM staging criteria from the AJCC to create an easy-to-use and interactive functionality that offer access to the 7th and 8th Edition of the staging criteria.

Drug Interaction Checker

This allows you to quickly search combinations of drug interactions to identify if they are safe to use.

RED IPHONE

Drug Info

An organized drug info section derived from SMPC in an easy-to-navigate structure, allows the user to jump in and out of a specific section quickly.

Advanced Myelofibrosis scoring tool

 

ONCOnews

From breaking news and conference coverage to in-depth analysis, we bring together all your news sources in one place.

Video

All the latest videos from Dr. Gil Morgan and interviews with prominent members of the oncology community.

RADIO icon

Oncology Spotlight

Where we interview prominent members of the oncology community and shed light on opportunities and challenges in practice today.